|
|
|
Cadmium chloride in 0.1 M HCl. |
|
|
1.85-37 MBq/µg Cd, 50-1000
µCi/µg Cd. |
|
|
Dispensed to order. |
|
|
Available 1-3 days from
receipt of order. |
|
| |
|
|
|
|
(3-[125I]iodotyrosyl12)Calcitonin, human |
|
|
|
Freeze-dried solid. |
|
|
~ 74 TBq/mmol, ~ 2000 Ci/mmol. |
|
| |
|
| |
|
(3-[125I]iodotyrosyl22)Calcitonin, salmon |
|
|
|
Freeze-dried solid. |
|
|
~ 74 TBq/mmol, ~ 2000 Ci/mmol. |
|
| |
|
|
|
|
(2-[125I]iodohistidyl10)Calcitonin gene-related peptide, human
([125I]CGRP) |
|
|
|
Freeze-dried solid. |
|
|
~ 74 TBq/mmol, ~ 2000 Ci/mmol. |
|
| |
|
|
|
|
|
|
Calcium chloride in aqueous solution. |
|
|
0.185-1.85 GBq/mg Ca, 5-50
mCi/mg Ca. |
|
|
Available from stock. |
|
| |
|
|
|
|
|
|
Gas in break-seal flask. |
|
|
1.85-2.2 GBq/mmol, 50-60 mCi/mmol. |
|
| |
|
|
|
|
|
|
Liquid in break-seal ampoule. |
|
|
1.85-2.29 GBq/mmol, 50-62 mCi/mmol. |
|
| |
|
|
|
|
5-Carboxamido[3H]tryptamine, trifluoroacetate |
|
|
|
Ethanol:water (1:1) containing 0.1% trifluoroacetic acid. |
|
|
Specific activity: 1.85-3.7
TBq/mmol, 50-100
Ci/mmol. |
|
|
7.4 MBq/ml, 200 µCi/ml. |
|
|
Kd = 0.76 nM
(guinea pig brain)(1). |
|
|
[3H]5-Carboxamidotryptamine
is supplied as a solution in ethanol:water:trifluoroacetic acid
(50:50:0.1) in a 3.7 MBq, 100 µCi pack size. |
|
| |
|
|
|
|
l-[methyl-14C]Carnitine hydrochloride |
|
|
|
Aqueous solution, sterilized. |
|
|
1.85-2.29 GBq/mmol, 50-62
mCi/mmol. |
|
|
740 kBq/ml, 20 µCi/ml. |
|
| |
|
|
|
|
l-[methyl-3H]Carnitine hydrochloride |
|
|
|
Ethanol:water (1:1) solution. |
|
|
2.2-3.18 TBq/mmol, 60-86
Ci/mmol. |
|
|
37 MBq/ml, 1 mCi/ml. |
|
| |
|
|
|
|
CCK-8 (sulfated), 125I-labelled with Bolton & Hunter reagent |
|
|
|
Freeze-dried solid. |
|
|
~ 74 TBq/mmol, ~ 2000 Ci/mmol. |
|
| |
|
|
|
|
CCK-8 (sulfated), [propionyl-3H]propionylated |
|
|
|
Triethylammonium phosphate, pH 3.4:acetonitrile (1:1) solution
containing 0.2% v/v mercaptoethanol. |
|
|
2.2-3.7 TBq/mmol, 60-100
Ci/mmol. |
|
|
7.4 MBq/ml, 200 µCi/ml. |
|
| |
|
|
|
|
|
|
Ethanol solution. |
|
|
1.11-2.22 TBq/mmol, 30-60
Ci/mmol. |
|
|
37 MBq/ml, 1 mCi/ml. |
|
| |
|
|
|
|
d-threo-[dichloroacetyl-1-14C]- Chloramphenicol |
|
|
|
Aqueous solution containing 2% ethanol, sterilized. |
|
|
1.85-2.29 GBq/mmol, 50-62
mCi/mmol. |
|
|
7.4 MBq/ml, 200 µCi/ml. |
|
| |
|
|
|
|
d-threo-[dichloroacetyl-1-14C]- Chloramphenicol (CAT assay
grade) |
|
|
|
0.25 M tris HCl buffer solution, pH 7.5, sterilized. |
|
|
1.85-2.29 GBq/mmol, 50-62
mCi/mmol. |
|
|
925 kBq/ml, 25 µCi/ml. |
|
| |
|
|
|
|
|
|
Sodium chloride in aqueous solution. |
|
|
< 111 MBq/g Cl, < 3 mCi/g Cl. |
|
|
Available on request. |
|
|
Please inquire for alternative pack sizes. |
|
| |
|
|
|
|
|
|
Sodium chloride in aqueous solution. |
|
|
< 111 MBq/g Cl, < 3 mCi/g Cl. |
|
|
Available on request. |
|
|
Please inquire for alternative pack sizes. |
|
| |
|
|
|
|
4-Chloro[ring-U-14C]benzoic acid |
|
|
|
Solid in sealed ampoule. |
|
|
3.7-4.59 GBq/mmol, 100-124 mCi/mmol. |
|
|
Available 4 weeks from date of order. |
|
| |
|
|
|
|
|
|
Ethanol solution. |
|
|
1.85-2.29 GBq/mmol, 50-62
mCi/mmol. |
|
|
1.85 MBq/ml, 50 µCi/ml. |
|
| |
|
|
|
|
|
|
Toluene solution. |
|
|
1.85-2.29 GBq/mmol, 50-62
mCi/mmol. |
|
|
3.7 MBq/ml, 100 µCi/ml. |
|
| |
|
|
|
|
|
|
Toluene solution. |
|
|
1.3-1.85 TBq/mmol, 35-50
Ci/mmol. |
|
|
37 MBq/ml, 1 mCi/ml. |
|
| |
|
|
|
|
|
|
Toluene solution. |
|
|
74-296 GBq/mmol, 2-8
Ci/mmol. |
|
|
37 MBq/ml, 1 mCi/ml. |
|
| |
|
|
|
|
[1a,2a(n)-3H]Cholesteryl linoleate |
|
|
|
Toluene solution. |
|
|
General purpose. |
|
|
1.1-2.2 TBq/mmol, 30-60
Ci/mmol. |
|
|
37 MBq/ml, 1 mCi/ml. |
|
| |
|
|
|
|
[1a,2a(n)-3H]Cholesteryl oleate |
|
|
|
Toluene solution. |
|
|
1.1-2.2 TBq/mmol, 30-60
Ci/mmol. |
|
|
37 MBq/ml, 1 mCi/ml. |
|
| |
|
|
|
|
|
|
Toluene solution. |
|
|
1.85-2.29 GBq/mmol, 50-62
mCi/mmol. |
|
|
3.7 MBq/ml, 100 µCi/ml. |
|
| |
|
|
|
|
[methyl-14C]Choline chloride |
|
|
|
Aqueous solution containing 2% ethanol, sterilized. |
|
|
1.85-2.29 GBq/mmol, 50-62
mCi/mmol. |
|
|
7.4 MBq/ml, 200 µCi/ml. |
|
| |
|
|
|
|
[methyl-3H]Choline chloride |
|
|
|
Ethanol solution. |
|
|
2.22-3.14 TBq/mmol, 60-85
Ci/mmol. |
|
|
37 MBq/ml, 1 mCi/ml. |
|
| |
|
|
|
|
|
|
Sodium chromate in sodium chloride solution, sterilized. |
|
|
> 9.25 GBq/mg Cr, > 250 mCi/mg Cr. |
|
|
37 MBq/ml, 1 mCi/ml. |
|
|
Available from stock. |
|
|
Please inquire for larger pack sizes. |
|
| |
|
|
|
|
|
|
Sodium chromate in aqueous solution. |
|
|
> 9.25 GBq/mg Cr, > 250 mCi/mg Cr. |
|
|
37 MBq/ml, 10-35 mCi/ml. |
|
|
Available from stock. |
|
|
Please inquire for larger pack sizes. |
|
| |
|
|
|
|
|
|
Sodium chromate in sodium chloride solution, sterilized. |
|
|
> 9.25 GBq/mg Cr, > 250 mCi/mg Cr. |
|
|
37 MBq/ml, 1 mCi/ml. |
|
|
Available from stock. |
|
|
Please inquire for larger pack sizes. |
|
| |
|
|
|
|
|
|
Ethanol solution. |
|
|
1.11-2.22 TBq/mmol, 30-60
Ci/mmol. |
|
|
37 MBq/ml, 1 mCi/ml. |
|
|
Made to order, please inquire for availability. |
|
| |
|
|
|
|
|
|
Ethanol solution. |
|
|
0.37-1.11 TBq/mmol, 10-30
Ci/mmol. |
|
|
37 MBq/ml, 1 mCi/ml. |
|
| |
|
|
|
|
|
|
Ethanol solution. |
|
|
Specific activity: 2.22-3.18
TBq/mmol, 60-86
Ci/mmol |
|
|
37 MBq/ml, 1 mCi/ml. |
|
|
Kd = 1.32 nM
(rat cortex membrane)(3). |
|
|
[3H]Citalopram
is supplied as a solution in ethanol in 1.85 MBq, 50 µCi and 9.25 MBq,
250 µCi pack sizes. |
|
|
Selective 5-Hydroxytryptamine (5-HT) uptake inhibitor. |
|
|
Therapeutically favorable for the treatment of mood, anxiety and eating
disorders. |
|
|
Used to assess the integrity of the 5-HT system in Parkinson's disease
by autoradiography. |
|
| |
|
|
|
|
|
|
Aqueous solution containing 2% ethanol, sterilized. |
|
|
3.7-4.6 GBq/mmol, 100-124
mCi/mmol. |
|
|
1.85 MBq/ml, 50 µCi/ml. |
|
| |
|
|
|
|
|
|
Cobalt(II) chloride in 0.1 M HCl. |
|
|
150-315 MBq/µg Co, 4-8.4
mCi/µg Co. |
|
|
Available 5-7 days from
receipt of order. |
|
|
Please inquire for larger pack sizes. |
|
| |
|
|
|
|
(3-[125I]iodotyrosyl22)w-Conotoxin GVIA |
|
|
|
Freeze-dried solid. |
|
|
~ 74 TBq/mmol, ~ 2000 Ci/mmol. |
|
|
Made to order, please inquire for availability. |
|
| |
|
|
|
|
|
|
Freeze-dried solid. |
|
|
~ 74 TBq/mmol, ~ 2000 Ci/mmol. |
|
|
Made to order, please inquire for availability. |
|
| |
|
|
|
|
|
|
Freeze-dried solid. |
|
|
~ 74 TBq/mmol, ~ 2000 Ci/mmol. |
|
|
Made to order, please inquire for availability. |
|
| |
|
|
|
|
[1,2,6,7-3H]Corticosterone |
|
|
|
Toluene:ethanol (9:1) solution. |
|
|
2.8-3.9 TBq/mmol, 75-105
Ci/mmol. |
|
|
37 MBq/ml, 1 mCi/ml. |
|
| |
|
|
|
|
(2-[125I]iodohistidyl32)Corticotropin releasing factor (CRF),
human |
|
|
|
Freeze-dried solid. |
|
|
~ 74 TBq/mmol, ~ 2000 Ci/mmol. |
|
| |
|
|
|
|
|
|
Toluene:ethanol (9:1) solution. |
|
|
1.85-3.33 TBq/mmol, 50-90
Ci/mmol. |
|
|
37 MBq/ml, 1 mCi/ml. |
|
| |
|
|
|
|
Cortisol-3-(O-carboxymethyl) oximino- (2-[125I]iodohistamine) |
|
|
|
Methanol:water (9:1) solution. |
|
|
~ 74 TBq/mmol, ~ 2000 Ci/mmol. |
|
|
3.7 MBq/ml, 100 µCi/ml. |
|
| |
|
|
|
|
|
|
Specific activity: 1.11-2.22TBq/mmol,
30-60 Ci/mmol. |
|
|
[3H] Cortisone
is supplied as an ethanol solution in 9.25 MBq, 250 µCi and 37 MBq, 1
mCi pack sizes. |
|
| |
|
|
|
|
[propyl-3H]8-Cyclopentyl-1,3-dipropylxanthine ([3H] DPCPX) |
|
|
|
Ethanol solution. |
|
|
Specific activity: 2.96-4.81 TBq/mmol, 80-130 Ci/mmol. |
|
|
7.4 MBq/ml, 200 µCi/ml. |
|
|
Kd= 0.18 nM
(rat brain membrane)(3). |
|
|
Low non-specific binding (<10%)(3). |
|
|
High selectivity (>1000 fold v A2)(3). |
|
|
[3H]8-Cyclopentyl-1,3-dipropylxanthine
is supplied as a solution in ethanol in 1.85 MBq, 50 µCi and 9.25 MBq,
250 µCi pack sizes. |
|
| |
|
|
|
|
[mebmt-b-3H]Cyclosporin-A (methyl-butenyl-methyl-threonine-b-3H)
|
|
|
|
Ethanol solution. |
|
|
185-740 GBq/mmol, 5-20
Ci/mmol. |
|
|
37 MBq/ml, 1 mCi/ml. |
|
| |
|
|
|
|
|
|
As hydrochloride in aqueous solution. |
|
|
3.7-5.5 GBq/mmol, 100-150
mCi/mmol. |
|
|
555 MBq/ml, 15 mCi/ml. |
|
| |
|
|
|
|
|
|
As hydrochloride in aqueous solution. |
|
|
3.7-5.5 GBq/mmol, 100-150
mCi/mmol. |
|
|
555 MBq/ml, 15 mCi/ml. |
|
| |
|
|
|
|
|
|
As hydrochloride in aqueous solution. |
|
|
3.7-5.5 GBq/mmol, 100-150
mCi/mmol. |
|
|
555 MBq/ml, 15 mCi/ml. |
|
| |
|
|
|
|
|
|
Solid. |
|
|
1.5-9.3 GBq/mmol, 40-250
mCi/mmol. |
|
| |
|
|
|
|
Cytidine 3',5'-bis [a-32P] phosphate, triethylammonium salt
(pCp) |
|
|
|
Stabilized aqueous solution containing 5 mM 2-mercaptoethanol. |
|
|
~ 110 TBq/mmol, ~ 3000 Ci/mmol. |
|
|
370 MBq/ml, 10 mCi/ml. |
|
| |
|
|
|
|
[5-3H]Cytidine 5'-diphosphate, ammonium salt |
|
|
|
Ethanol:water (1:1) solution. |
|
|
General purpose. |
|
|
0.37-1.11 TBq/mmol, 10-30
Ci/mmol. |
|
|
37 MBq/ml, 1 mCi/ml. |
|
| |
|
|
|
|
Cytidine 5'-monophospho[4,5,6,7,8,9-14C] sialic acid, ammonium
salt |
|
|
|
Aqueous solution containing 0.02 M ammonium bicarbonate and 2% ethanol,
sterilized. |
|
|
5.55-11.5 GBq/mmol, 150-310
mCi/mmol. |
|
|
925 kBq/ml, 25 µCi/ml. |
|
| |
|
|
|
|
Cytidine 5'-[a-35S]thiotriphosphate, triethylammonium salt |
|
|
|
Stabilized aqueous solution containing 20 mM DTT. |
|
|
> 37 TBq/mmol, > 1000 Ci/mmol. |
|
|
370 MBq/ml, 10 mCi/ml. |
|
|
QC-tested using typical DNA-labeling protocol. |
|
| |
|
|
|
|
Cytidine 5'-[a-35S]thiotriphosphate, triethylammonium salt
(SP6/T7 grade) |
|
|
|
Stabilized aqueous solution containing 20 mM DTT. |
|
|
~ 30 TBq/mmol, ~ 800 Ci/mmol. |
|
|
1.5 GBq/ml, 40 mCi/ml. |
|
|
QC-tested using typical DNA-labeling protocol. |
|
| |
|
|
|
|
[5-3H]Cytidine 5'-triphosphate, ammonium salt |
|
|
|
Ethanol:water (1:1) solution. |
|
|
550-925 GBq/mmol, 15-25
Ci/mmol. |
|
|
37 MBq/ml, 1 mCi/ml. |
|
| |
|
| |
|
Cytidine 5'-[a-32P]triphosphate, triethylammonium salt |
|
|
|
Stabilized aqueous solution containing 5 mM 2-mercaptoethanol. |
|
|
~ 110TBq/mmol, ~ 3000 Ci/mmol. |
|
|
370 MBq/ml, 10 mCi/ml. |
|
|
QC-tested using typical SP6/T7 transcription protocol. |
|
| |
|
| |
|
Cytidine 5'-[a-32P]triphosphate, triethylammonium salt |
|
|
|
Stabilized aqueous solution containing 5 mM 2-mercaptoethanol. |
|
|
~ 15 TBq/mmol, ~ 400 Ci/mmol. |
|
|
370 MBq/ml, 10 mCi/ml. |
|
|
QC-tested using typical SP6/T7 transcription protocol. |
|
| |
|
| |
|
Cytidine 5'-[a-32P]triphosphate, triethylammonium salt (SP6/T7
grade) |
|
|
|
Stabilized aqueous solution. |
|
|
~ 30 TBq/mmol, ~ 800 Ci/mmol. |
|
|
1.5 GBq/ml, 40 mCi/ml. |
|
|
QC-tested using typical SP6/T7 transcription protocol. |
|
| |
|
| |
|
Cytidine 5'-[a-32P]triphosphate, triethylammonium salt (SP6/T7
grade) |
|
|
|
Stabilized aqueous solution. |
|
|
~ 30 TBq/mmol, ~ 800 Ci/mmol. |
|
|
1.5 GBq/ml, 40 mCi/ml. |
|
|
QC-tested using typical SP6/T7 transcription protocol. |
|
| |
|
| |
|
|
|
Ethanol solution. |
|
|
General purpose. |
|
|
370-740 GBq/mmol, 10-20
Ci/mmol. |
|
|
18.5 MBq/ml, 500 µCi/ml. |
|